Medicine guide

Tremfya 45 mg/0.45 ml

As listed in the register: Tremfya 45 mg/0.45 ml, Injektionslösung im Fertigpen

45 mg/0.45 ml ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Guselkumabum
Made by
Janssen-Cilag AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Plaque Psoriasis (Erwachsene und pädiatrische Patienten ab 6 Jahren), Psoriasis-Arthritis (Erwachsene), Morbus Crohn (Erwachsene), Colitis ulcerosa (Erwachsene)

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byJanssen-Cilag AG
Active substanceGuselkumabum
Used inCancer treatments and immune-system medicines
Strength45 mg/0.45 ml
ClassificationL04AC16 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerTremfya 45 mg/0.45 ml, Injektionslösung im Fertigpen
Packs1 Injektor(en), vorgefüllt/Pen
Zulassungsnummer67490
Dosisstärke3

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.